BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1390 related articles for article (PubMed ID: 789043)

  • 1. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of venous thromboembolism.
    Gallus AS; Hirsh J
    Semin Thromb Hemost; 1976 Apr; 2(4):232-90. PubMed ID: 798276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
    Di Minno G; Tufano A; Cerbone AM
    Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in the prevention and treatment of pulmonary embolism.
    Agnelli G
    Chest; 1995 Jan; 107(1 Suppl):39S-44S. PubMed ID: 7813328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulants in the prevention of venous thromboembolism.
    Gallus AS
    Baillieres Clin Haematol; 1990 Jul; 3(3):651-84. PubMed ID: 2148697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis: the relationship of hemostatic mechanisms to drug therapy.
    Wessler S; Gitel SN
    J Neurosurg; 1981 Jan; 54(1):1-11. PubMed ID: 7007586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of venous thromboembolism.
    Hirsh J
    Nouv Rev Fr Hematol (1978); 1988; 30(3):149-53. PubMed ID: 3047668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 16. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic drugs: part II.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(2):132-57. PubMed ID: 786606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventing venous thromboembolism].
    Encke A; Haas S
    Chirurg; 2007 Feb; 78(2):110, 112-8. PubMed ID: 17265054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.